Teladoc Health, Inc. Chief Financial Officer Michael F. Grasher filed a Form 4 on September 1, 2026, disclosing the acquisition of 239,616 restricted stock units in Teladoc Health common stock.

Key Highlights

  • Grant date: The transaction date is reported as September 1, 2026.
  • Security granted: 239,616 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock.
  • Price: The RSUs were acquired at $0.
  • Vesting schedule: One-half vest on the first anniversary of the grant date, with the remainder vesting in six substantially equal quarterly installments thereafter.
  • Post-transaction ownership: Grasher beneficially owns 239,616 derivative securities following the reported transaction, held directly.
  • Reporting person role: Michael F. Grasher is identified as Chief Financial Officer of Teladoc Health, Inc.

Details of the RSU Grant to Teladoc Health's Chief Financial Officer

According to the filing, Michael F. Grasher, Chief Financial Officer of Teladoc Health, Inc. (NYSE:TDOC), acquired 239,616 restricted stock units on September 1, 2026, under transaction code "A" (acquired). The filing states that each restricted stock unit "represents a contingent right to receive one share of TDOC common stock." The price of the derivative security is listed as $0, and the ownership form is reported as direct.

The filing describes the vesting terms as follows: "One-half of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in six substantially equal quarterly installments thereafter." No expiration date is specified for the exercisability of the RSUs in the filing. Following the reported transaction, the filing discloses that Grasher beneficially owns 239,616 derivative securities in total.

The Form 4 was signed by Adam C. Vandervoort as Attorney-in-Fact on September 1, 2026. No transactions were reported in Table I covering non-derivative securities. The filing does not indicate that this grant was made pursuant to a Rule 10b5-1(c) plan, as that box was not checked.

What Was Disclosed

The Form 4 filed by Teladoc Health CFO Michael F. Grasher on September 1, 2026, discloses the acquisition of 239,616 RSUs at $0, with a phased vesting schedule beginning on the first anniversary of the grant date.